SUBSCRIPTION AGREEMENT CBD Life Sciences, Inc. NOTICE TO INVESTORSSubscription Agreement • August 18th, 2022 • CBD Life Sciences Inc. • Medicinal chemicals & botanical products • Nevada
Contract Type FiledAugust 18th, 2022 Company Industry JurisdictionThe securities of CBD Life Sciences, Inc., a Nevada corporation (the “Company”), to which this Subscription Agreement relates, represent an investment that involves a high degree of risk, suitable only for persons who can bear the economic risk for an indefinite period of time and who can afford to lose their entire investments. Investors should further understand that this investment is illiquid and is expected to continue to be illiquid for an indefinite period of time. No public market exists for the securities to which this Subscription Agreement relates.